CXL Ophthalmics, Inc.
Pharmaceutical company · Sherborn, Massachusetts, United States
CXL Ophthalmics, Inc. is a pharmaceutical company headquartered in Sherborn, Massachusetts, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $26 million sold in a notice filed in 2022.
CXL Ophthalmics at a glance
What does CXL Ophthalmics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $26.4 million sold (2022).
Frequently asked questions about CXL Ophthalmics
Where is CXL Ophthalmics headquartered?
CXL Ophthalmics, Inc. is headquartered in Sherborn, Massachusetts, United States.
What does CXL Ophthalmics do?
CXL Ophthalmics, Inc. is a pharmaceutical company.
When was CXL Ophthalmics founded?
The earliest incorporation on record for CXL Ophthalmics, Inc. is in 2022, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences